Pomegra
Argus Research raises Boeing to Buy with a $65 price target, citing recovered 787 Dreamliner output and stabilizing aircraft assembly operations as catalysts for a projected 14% gain.
- Argus lifts BA to Buy from Hold, setting a $65 price target implying roughly 14% upside from current levels.
- The Boeing 787 Dreamliner program's resumed deliveries and improving aircraft assembly throughput underpin the bullish thesis.
- Boeing's commercial backlog, exceeding 5,600 aircraft, provides multi-year revenue visibility as air travel demand remains firm.
Lead
Argus Research upgraded Boeing (NYSE: BA) to Buy from Hold on Thursday, assigning a $65 price target that implies approximately 14% upside. The call centers on a meaningful recovery in Boeing 787 Dreamliner production and broader stabilization across aircraft assembly operations — two metrics that had weighed on the aerospace giant's financials and investor confidence for the better part of three years.What Happened
Argus analysts cited tangible operational progress as the primary driver of the upgrade. Boeing's troubled 787 program, which experienced an extended delivery halt due to manufacturing defects in fuselage join sections, has returned to a more normalized cadence. Monthly 787 deliveries have climbed back toward previously targeted rates, easing near-term revenue pressure on the commercial aviation segment.
The upgrade also reflects broader confidence in Boeing's path to recovering aircraft assembly efficiency. The company has been methodically addressing quality control issues across its Everett and North Charleston facilities, implementing additional inspection protocols and reworking supplier coordination following intense Federal Aviation Administration scrutiny. Those efforts appear to be yielding measurable gains in throughput and defect rates.
Market Reaction
Shares of BA responded positively to the Argus call, extending a recovery that has been building as delivery numbers improved. The stock has faced significant pressure over the past several years — falling from prior highs above $400 — as the 737 MAX crises, pandemic-era demand collapse, and 787 production stoppages compounded. The $65 Argus target, while well below historical peaks, signals that the analyst community is beginning to price in a credible recovery rather than continued deterioration.
Trading volumes in BA options and equity alike have elevated on analyst upgrade days in recent months, reflecting heightened institutional attention to inflection signals in the commercial aerospace cycle.
Strategic Context
Boeing's commercial backlog remains one of the largest in aviation history — over 5,600 aircraft — representing more than seven years of production at current assembly rates. That pipeline, anchored heavily by the 737 MAX family and the long-range Boeing 787 Dreamliner, provides substantial forward revenue visibility that analysts increasingly view as underappreciated at current share price levels.The 787 Dreamliner is of particular strategic importance. As a wide-body twin-aisle jet favored by carriers on long-haul international routes, 787 deliveries carry significantly higher revenue recognition per unit than narrow-body jets. Each recovered delivery quarter translates directly to improved cash flow — a metric that has been the central concern for Boeing investors and credit analysts alike.
Aircraft assembly capacity constraints have also eased modestly on the supplier side, as engine makers and key component vendors have worked to rebuild inventories and staffing following pandemic-era dislocations. This supply chain normalization, while still incomplete, reduces a key risk that had previously caused analysts to discount delivery guidance.Industry and Competitive Dimension
Airbus (OTC: EADSY) continues to capitalize on Boeing's difficulties, capturing orders from carriers that might historically have split fleets between the two manufacturers. The A350, Airbus's primary competitor to the Boeing 787, has benefited from production consistency that Boeing struggled to match. However, Argus and other analysts note that Boeing's order book remains robust — airlines with existing fleet standardization around Boeing platforms have limited near-term incentive to switch, particularly given Airbus's own production bottlenecks.The commercial aerospace duopoly dynamic means that even a partially recovered Boeing benefits from structural demand that cannot be met by new entrants in the foreseeable future. Global passenger traffic is tracking ahead of pre-pandemic levels in most major markets, and fleet renewal cycles — driven by fuel efficiency mandates and aging narrowbody and widebody retirements — sustain multi-decade demand.
Regulatory and Operational Overhang
Boeing continues to operate under elevated FAA oversight, including production rate caps on the 737 MAX that limit how quickly narrow-body output can scale. The company also faces ongoing litigation and settlement costs tied to prior safety incidents. Argus's upgrade implicitly assumes these headwinds are manageable and increasingly priced into current valuations, rather than sources of new negative surprise.Progress on aircraft assembly quality metrics will remain a closely watched indicator. Any reemergence of systemic defect rates or renewed regulatory action could delay the delivery recovery thesis — and would likely prompt reassessment of the bullish call.
